June 11th 2025, 5:00pm
Two people connect by sharing their experiences about taking care of their spouses who died from cancer, and the realization that sparked something more.
June 11th 2025, 4:30pm
Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with polycythemia vera.
June 11th 2025, 3:00pm
FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.
June 10th 2025, 9:00pm
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
June 10th 2025, 8:00pm
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
June 10th 2025, 7:00pm
Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell lung cancer.
June 10th 2025, 5:00pm
I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still searching for peace.
June 10th 2025, 4:00pm
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
June 10th 2025, 3:18pm
The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.
June 10th 2025, 1:00pm
The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.
Understanding Thymoma Cancer and Its Treatment Options: A Patient Guide
Understanding Your Diagnosis: Stage 2 Oral Cavity Cancer
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer